anti-Nipah browse page allows user to take a glance of the particular anti-Nipah ihibitor.By clicking on the table header arrows, user can sort entries in ascending or descending order.Moreover, the user can get the detal of every inhibitor by clicking on individual ID.


Total number of Records for Plaque assay are 42




anti-Nipah_ID Drug Name
Nipah virus strain
Assay
Activity Type
Activity
References
anti-Nipah_235Chloroquine
Nipah virus Malaysia
Plaque assay
Inhibitory concentration
50 %
19889926
anti-Nipah_236Ribavirin
Nipah virus Malaysia
Plaque assay
Inhibitory concentration
50 %
19889926
anti-Nipah_240Favipiravir
Nipah virus Malaysia
Plaque assay
Effective concentration
50 %
29765101
anti-Nipah_241Favipiravir
Nipah virus Bangladesh
Plaque assay
Effective concentration
50 %
29765101
anti-Nipah_242Favipiravir
Nipah virus rNiV-Gluc-eGFP
Plaque assay
Effective concentration
50 %
29765101
anti-Nipah_277(5Z)-5-[(5-phenylfuran-2-yl)methylidene]-3-prop-2-enyl-2-sulfanylidene-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_278(5Z)-3-Ethyl-5-[(5-phenyl-2-furyl)methylene]-2-thioxo-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_279(5Z)-5-[(5-Phenyl-2-furyl)methylene]-3-propyl-2-thioxo-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_280(5Z)-3-Benzyl-5-[(5-phenyl-2-furyl)methylene]-2-thioxo-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_281(5Z)-3-Methyl-5-[(5-phenyl-2-furyl)methylene]-2-thioxo-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_282(5Z)-5-{[5-(3-Chlorophenyl)-2-furyl]methylene}-3-ethyl-2-thioxo-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_283(5Z)-3-Ethyl-5-{[5-(3-fluorophenyl)-2-furyl]methylene}-2-thioxo-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_2843-Ethyl-5-{[5-(2-fluorophenyl)-2-furyl]methylene}-2-thioxo-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_285(5Z)-5-{[5-(2-Chlorophenyl)-2-furyl]methylene}-3-ethyl-2-thioxo-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_286(5Z)-3-ethyl-5-{[5-(2-methoxyphenyl)furan-2-yl]methylidene}-2-sulfanylidene-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_287(5Z)-3-ethyl-5-{[5-(3-methoxyphenyl)furan-2-yl]methylidene}-2-sulfanylidene-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_288(5Z)-3-Ethyl-2-thioxo-5-({5-[2-(trifluoromethyl)phenyl]-2-furyl}methylene)-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_289(5Z)-3-Ethyl-5-[(5-methyl-2-furyl)methylene]-2-thioxo-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_290(5Z)-3-Ethyl-5-(2-furylmethylene)-2-thioxo-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_291(5Z)-3-Ethyl-5-{[5-(2-nitrophenyl)-2-furyl]methylene}-2-thioxo-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_292(5Z)-3-ethyl-5-{[5-(2-hydroxyphenyl)furan-2-yl]methylidene}-2-sulfanylidene-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_293(5Z)-5-{[5-(2-aminophenyl)furan-2-yl]methylidene}-3-ethyl-2-sulfanylidene-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_294(5Z)-3-ethyl-5-[(5-phenylthiophen-2-yl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_295(5Z)-5-({[1,1-biphenyl]-3-yl}methylidene)-3-ethyl-2-sulfanylidene-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_2962-(5-{[(5Z)-3-ethyl-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]methyl}furan-2-yl)benzene-1-diazonium; tetrafluoroboranuide
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_2973-[(5Z)-4-oxo-5-[(5-phenylfuran-2-yl)methylidene]-2-sulfanylidene-1,3-thiazolidin-3-yl]propyl acetate
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_298(5Z)-3-(3-hydroxypropyl)-5-[(5-phenylfuran-2-yl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_299(5Z)-3-ethyl-5-[(2-phenyl-1,3-oxazol-5-yl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_300 3-[(5Z)-4-oxo-5-[(5-phenylfuran-2-yl)methylidene]-2-sulfanylidene-1,3-thiazolidin-3-yl]propyl 4-{2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl}butanoate
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_301(5Z)-5-[(5-Phenyl-2-furyl)methylene]-2-thioxo-3-vinyl-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_302(5Z)-3-Ethyl-5-{[5-(2-nitrophenyl)-2-furyl]methylene}-1,3-thiazolidine-2,4-dione
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_303(5Z)-3-ethenyl-5-[(5-phenylfuran-2-yl)methylidene]-1,3-thiazolidine-2,4-dithione
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_304(5Z)-3-ethyl-5-{[5-(2-nitrophenyl)furan-2-yl]methylidene}-1,3-thiazolidine-2,4-dithione
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_305(5Z)-3-ethenyl-5-[(5-phenylfuran-2-yl)methylidene]-4-sulfanylidene-1,3-thiazolidin-2-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_306(5Z)-3-ethyl-5-{[5-(2-nitrophenyl)furan-2-yl]methylidene}-4-sulfanylidene-1,3-thiazolidin-2-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_307(5Z)-5-[(5-Phenyl-2-furyl)methylene]-2-thioxo-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_308(5Z)-5-[(5-phenylfuran-2-yl)methylidene]-3-(prop-2-yn-1-yl)-2-sulfanylidene-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_3095-[(5-phenylfuran-2-yl)methyl]-3-(prop-2-en-1-yl)-2-sulfanylidene-1,3-thiazolidin-4-one
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_310N-{3-[(5Z)-2,4-dioxo-5-[(5-phenylfuran-2-yl)methylidene]-1,3-thiazolidin-3-yl]propyl}acetamide
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_311(5Z)-3-(3-aminopropyl)-5-[(5-phenylfuran-2-yl)methylidene]-1,3-thiazolidine-2,4-dione
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_3122-methylpropyl N-{3-[(5Z)-4-oxo-5-[(5-phenylfuran-2-yl)methylidene]-2-sulfanylidene-1,3-thiazolidin-3-yl]propyl}carbamate
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A
anti-Nipah_3133-[(5Z)-2,4-dioxo-5-[(5-phenylfuran-2-yl)methylidene]-1,3-thiazolidin-3-yl]propyl 4-{2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl}butanoate
Nipah virus NiV-pVSV
Plaque assay
Inhibitory concentration
50 %
WO2010044924A